METABOLIC RISK FACTORS IN PATIENTS WITH ARTERIAL HYPERTENSION

被引：0
|
作者：
Badrakh, Burmaa [1 ]
Unurjargal, Tsolmon [1 ]
Sukhbaatar, Amarjargal [1 ]
Myagmardorj, Rinchyenkhand [1 ]
机构：
[1] Mongolian Natl Univ Med Sci, Cardiol, Ulaanbaatar, Mongolia
来源：
JOURNAL OF HYPERTENSION | 2018年 / 36卷
关键词：
metabolic risk factor; metabolic syndrome; arterial hypertension;
D O I：
10.1097/01.hjh.0000548585.88797.3e
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
A3153
引用
收藏
页码：E145 / E145
页数：1
相关论文
共 50 条
  • [41] Reduced platelet aggregation in losartan-treated patients with arterial hypertension and metabolic syndrome
    Medvedev, I. N.
    Kumova, T. A.
    RUSSIAN JOURNAL OF CARDIOLOGY, 2008, (05): : 53 - 55
  • [42] THERAPEUTIC EFFICACY OF QUERCETIN IN PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC SYNDROME
    Bilovol, O. M.
    Kniazkova, I. I.
    Kuzminova, N., V
    Kirienko, O. M.
    Abramova, L. P.
    Gavrylyuk, A. O.
    WORLD OF MEDICINE AND BIOLOGY, 2021, 75 (01): : 18 - 22
  • [43] DETERMINATION OF RISK FACTORS FOR ARTERIAL HYPERTENSION IN STUDENTS OF UNIANDES AMBATO
    Nazate Chuga, Zuly Rivel
    Pozo Hernandez, Clara Elisa
    Guerron Enriquez, Sara Ximena
    REVISTA CONRADO, 2023, 19 : 243 - 250
  • [44] Prevalence and Risk Factors for Arterial Hypertension Development in Childhood Acute Lymphoblastic Leukemia Survivors
    Ociepa, Tomasz
    Bartnik, Magdalena
    Zielezinska, Karolina
    Urasinski, Tomasz
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2019, 41 (03) : 175 - 180
  • [45] Family Aggregation in Individuals with Essential Arterial Hypertension and Risk Factors
    Sanchez Delgado, Julio Armando
    Sanchez Lara, Naile Edita
    FINLAY, 2020, 10 (04): : 363 - 370
  • [46] Arterial hypertension and metabolic syndrome: specifics of antihypertensive therapy
    Abasova, L. I.
    Dashdamirov, R. L.
    Bakhshaliev, A. B.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2011, 10 (04): : 107 - 109
  • [47] Association Between Insulin Resistance and Other Metabolic Risk Factors in Patients with Hypertension and Subclinical Hypothyroidism
    Olena, Kolesnikova
    Anastasiia, Radchenko
    Valentine, Galchinskaya
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2021, 116 : 47 - 47
  • [48] The role of the matrix metalloproteinases in the development of left ventricular hypertrophy in patients with arterial hypertension and metabolic syndrome
    Zakirova, A. N.
    Fatkullina, E. Z.
    Zakirova, N. E.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2014, 10 (01) : 37 - 42
  • [49] Severity of carbohydrate metabolism disturbances, arterial hypertension stage, and lipid profile in patients with metabolic syndrome
    Zhernakova, Yu., V
    Chazova, I. E.
    Olimpieva, S. P.
    Kilikovskyi, V. V.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2012, 11 (02): : 13 - 18
  • [50] The role of hypersympathycotony in development of arterial hypertension in patients with metabolic syndrome: Potential of pathogenetically sound therapy
    Ametov, AS
    Demidova, TY
    Smagina, LV
    TERAPEVTICHESKII ARKHIV, 2004, 76 (12) : 27 - 32
12345